UNICYCIVE THERAPEUTICS, INC. Number of Reportable Segments
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Number of Reportable Segments of 100.00% for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2024-11-13
- UNICYCIVE THERAPEUTICS, INC. number of reportable segments for the quarter ending 2024-03-31 was 100.00%.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month |
|---|---|---|---|
| 2024-09-30 | 100.00% 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-13 | ||
| 2021-06-30 | 100.00% 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |